Reach Separations
Private Company
Total funding raised: $800K
Overview
Reach Separations is a specialized analytical and purification service provider founded in 2018 and based in Cambridge, UK. It operates as a contract research organization (CRO) utilizing advanced HPLC and SFC platforms to deliver fast turnaround for chiral and achiral separations, supporting drug discovery and development. In 2024, the company was strategically acquired by CatSci Ltd, integrating it into an end-to-end innovation partner for medicines development. This positions Reach Separations as a key service provider within a larger group, expanding its market reach and service capabilities.
Technology Platform
Utilizes High-Performance Liquid Chromatography (HPLC) and Supercritical Fluid Chromatography (SFC) for analytical and preparative-scale separation and purification of small molecules, with specialized automated screening for chiral separations.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
Reach Separations competes in the contract research organization (CRO) market, specifically against other providers of analytical and purification services. Its key differentiators are its specialized focus on chiral separations, the combined use of HPLC and SFC, and its emphasis on rapid turnaround. Being part of the CatSci Group now provides a competitive edge through integrated service offerings.